Literature DB >> 23045230

Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?

Pieter Evenepoel, Bjorn Meijers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23045230     DOI： 10.1038/nrneph.2012.219

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis.

Authors:  Paweena Susantitaphong; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2012-02       Impact factor: 8.860

Review 2.  Oral phosphate binders in patients with kidney failure.

Authors:  Marcello Tonelli; Neesh Pannu; Braden Manns
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

Review 3.  Uremic toxins originating from colonic microbial metabolism.

Authors:  Pieter Evenepoel; Bjorn K I Meijers; Bert R M Bammens; Kristin Verbeke
Journal:  Kidney Int Suppl       Date:  2009-12       Impact factor: 10.545

4.  Effects of phosphate binders in moderate CKD.

Authors:  Geoffrey A Block; David C Wheeler; Martha S Persky; Bryan Kestenbaum; Markus Ketteler; David M Spiegel; Matthew A Allison; John Asplin; Gerard Smits; Andrew N Hoofnagle; Laura Kooienga; Ravi Thadhani; Michael Mannstadt; Myles Wolf; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 10.121

5.  Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals.

Authors:  Jian-Su Shao; Su-Li Cheng; Joyce M Pingsterhaus; Nichole Charlton-Kachigian; Arleen P Loewy; Dwight A Towler
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

6.  Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.

Authors:  Kenneth Lim; Tzong-Shi Lu; Guerman Molostvov; Christina Lee; F T Lam; Daniel Zehnder; Li-Li Hsiao
Journal:  Circulation       Date:  2012-04-05       Impact factor: 29.690

7.  The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.

Authors:  D Russo; I Miranda; C Ruocco; Y Battaglia; E Buonanno; S Manzi; L Russo; A Scafarto; V E Andreucci
Journal:  Kidney Int       Date:  2007-09-05       Impact factor: 10.612

8.  Regulation of PTH1 receptor expression by uremic ultrafiltrate in UMR 106-01 osteoblast-like cells.

Authors:  Sinee Disthabanchong; Hatim Hassan; Charles L McConkey; Kevin J Martin; Esther A Gonzalez
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

9.  Calcium balance in chronic kidney disease: walking the tightrope.

Authors:  Pieter Evenepoel; Liesbeth Viaene; Bjorn Meijers
Journal:  Kidney Int       Date:  2012-06       Impact factor: 10.612

10.  Calcium deficiency reduces circulating levels of FGF23.

Authors:  María E Rodriguez-Ortiz; Ignacio Lopez; Juan R Muñoz-Castañeda; Julio M Martinez-Moreno; Alan Peralta Ramírez; Carmen Pineda; Antonio Canalejo; Philippe Jaeger; Escolastico Aguilera-Tejero; Mariano Rodriguez; Arnold Felsenfeld; Yolanda Almaden
Journal:  J Am Soc Nephrol       Date:  2012-05-10       Impact factor: 10.121
  10 in total
  1 in total

1.  Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?

Authors:  Lu Dai; Björn K Meijers; Bert Bammens; Henriette de Loor; Leon J Schurgers; Abdul Rashid Qureshi; Peter Stenvinkel; Pieter Evenepoel
Journal:  Toxins (Basel)       Date:  2020-05-27       Impact factor: 4.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.